Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,645,591
+$5,585,437 QoQ
Shares Held
10,543
+37.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,133
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Geneos Wealth Management Inc. holds $48,413,418 across 14 Drug Manufacturers - General names. LLY ranks #1 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
10,543 | $12,645,591 | |
| 2 | ABBV |
AbbVie Inc.
|
40,073 | $10,083,969 | |
| 3 | JNJ |
Johnson & Johnson
|
27,094 | $6,881,063 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
46,311 | $5,850,931 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
94,459 | $5,442,727 | |
| 6 | AMGN |
Amgen Inc
|
7,107 | $2,573,586 | |
| 7 | MRK |
Merck & Co., Inc.
|
14,481 | $1,860,808 | |
| 8 | NVS |
Novartis AG
|
11,132 | $1,744,607 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,645,591 | 10,543 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,060,154 | 7,676 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $7,869,882 | 7,323 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,717,922 | 7,494 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $7,022,006 | 9,008 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $9,528,523 | 11,537 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,624,532 | 8,581 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $8,008,011 | 9,039 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,219,039 | 9,078 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $7,619,340 | 9,794 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,380,934 | 9,231 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,306,307 | 9,879 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $4,591,314 | 9,790 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,798,186 | 8,148 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $3,280,121 | 8,966 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,037,226 | 9,393 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,399,801 | 13,570 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $3,975,388 | 13,882 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,114,296 | 14,895 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,737,695 | 16,177 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,738,651 | 16,289 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $2,526,740 | 13,525 | Shares | Sole | 2021-06-17 | |
| 2020-12-31 | $2,242,026 | 13,279 | Shares | Sole | 2021-05-19 | |
| 2020-09-30 | $2,002,414 | 13,528 | Shares | Sole | 2021-09-07 | |
| 2020-06-30 | $2,311,326 | 14,078 | Shares | Sole | 2021-09-07 | |
| 2020-03-31 | $1,967,604 | 14,184 | Shares | Sole | 2021-09-07 | |
| No filing history on record for this holder in this stock. | ||||||